Signatec Unveils PX14400, Its High-Speed PCI-Express Digitizer Capable of Sustained Recordings Over 1.2 GB/s with Xilinx Virtex-5 FPGAs for Embedded Real-Time ... (tribute to a broad selection of industry...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Signatec Unveils PX14400, Its High-Speed PCI-Express Digitizer Capable of Sustained Recordings Over 1.2 GB/s with Xilinx Virtex-5 FPGAs for Embedded Real-Time Processing

Date:9/15/2009

tribute to a broad selection of industry-standard solutions dedicated for use with Xilinx FPGAs.

About Signatec, Inc.
Delivering advanced system solutions since 1988, Signatec is a leading designer and manufacturer of high-speed data acquisition, parallel digital signal processing, continuous signal data recording and arbitrary waveform generation systems. Signatec differentiates itself by being one of the only single-source suppliers that works with its customers to build affordable, real-time signal technology systems for advanced radar, SIGINT, ultrasound, imaging and other high-speed communications systems. For more information, visit Signatec online at: www.signatec.com

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2881634.htm.

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Panther Expedited Services Unveils New Brand; Services Include Ground, Air, Ocean, & Logistics
2. ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey
3. MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC/eClinical Offering
4. Atherotech Unveils New Cardiometabolic Test Panels
5. DNA 11 Unveils Modern-Day Family Portraits at The Museum of Science and Industry's Smart Home: Green + WIRED Exhibit
6. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
7. Medicsight Unveils New Version of ColonCAD(TM) at ECR 2009
8. DuPont Unveils New Strategy to Expand its Seed Business
9. FBI unveils science of anthrax investigation
10. Video: Insulet Unveils Video Contest for OmniPod Users
11. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service

Post Your Comments:

(Date:11/20/2009)...Newswire/ -- Veridiam (www.veridiam.com) won the p...ategory at the 2009 Workplace Excellence Awards. T...or Human Resources Management and recognize innova..., Veridiam was one of nine winners, selected fro...red at the recent awards ceremony. San Diego-based...

(Date:11/20/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...he Ninth Circuit Court of Appeals reversed a U.S. ...allowed to pursue all of its claims against The La...urt for trial. CTI filed a complaint against The ... consultant for CTI,s product TRISENOX, in 2007 se...

(Date:11/19/2009)...Newswire/ -- Danish Prince Joachim inaugurated the...in Kalundborg, Denmark, on Wednesday, November 18....est 2nd generation ethanol demonstration biorefine...he plant,s innovative process for converting straw... first to market with commercial enzymes for conve...

(Date:11/19/2009)...ewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: N...ng letter to its shareholders, discussing the Comp...iopharmaceuticals Holdings, Inc. (CHBP), an integr...e,s Republic of China. The merger gives NeoStem a ...ical Co. Ltd., CHBP,s primary operating subsidiary...

Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2 Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2 DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2 NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2 NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3

[1] Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category [0] Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group [0] DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel [0] NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company

...M CONTINUES ITS EXPANSION INTO EUROPE AND STRENGTH...LE, Fla., May 12 OmniComm Systems, Inc. (OTC Bull...ronic data capture (EDC) solutions for clinical tr... European presence and management team with the ad...esident, Europe & Asia/Pacific based in OmniCo...

... Stock Exchange Symbol: MS , , EDMONTON, May 11 /...MS), a leading developer in the treatment of multi...operational results for the first quarter, ended M... results from MAESTRO-01, the first of our two piv... secondary progressive multiple sclerosis, in the ...

...RT, Mich., May 11 The following is being released...shareholders: , , As the founding CEO of Amylin a...to know how I plan to vote at our annual meeting. ... has created one of the best product and technolog..., shareholders have suffered because sales results...

OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific BioMS Medical Announces First quarter 2009 results Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate

(Date:11/22/2009)...team of pioneering South Korean scientists have su...y plastics through bioengineering, rather than thr...groundbreaking research, which may now allow for t...s, is published in two papers in the journal Biot...s 50th anniversary. , Polymers are molecules fo...

(Date:11/22/2009)...Cambridge, MA November 23, 2009 Agios Pharmaceut...ablished, for the first time, that the mutated IDH... a cancer-causing gene, or oncogene. This breakthr... produces a metabolite, 2-hydroxyglutarate (2HG), ...t progression of gliomas, the most common type of ...

(Date:11/20/2009)... a research report published in the November 2009 ...ics.org ), scientists show how a family of genes (... genes) are responsible for production of ethylene...nt, and this information lays the foundation for f...disease resistant, able to survive and thrive in d...

Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2 Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2 Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3 Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4 It's a gas: New discovery may lead to heartier, high-yielding plants 2 Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday November 9 2009 58885 1 Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday November 9 2009 58885 2 Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 1 Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 2 ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 1 ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 2 ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 3 ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 4

[3] Bioengineers succeed in producing plastic without the use of fossil fuels [0] Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer [0] It's a gas: New discovery may lead to heartier, high-yielding plants

...s announces the latest addition to its Cumulative ... (Cumitechs) publication series: Cumitech 46 -- L... Parasitic Diseases. , This Cumitech is intended ...d other members of the patient care team in the ap...ests for the diagnosis and management of blood-bor...

...ch team has developed the first small molecule tha...n balancing sodium levels, paving the way for drug...nditions. , The human epithelial sodium channel ...ch as the lungs, kidneys, and colon, and it is vit...essure. Interestingly, while there are available d...

...born in India and Sri Lanka are three times more l...n pregnancy (hyperemesis gravidarum) than ethnic N...nstitute of Public Healths study of 900, 000 first...Registry of Norway over a forty year period. , E...t women experience some degree of nausea and vomit...

Other Biology News:Extreme nausea and vomiting varies among pregnant women from different countries 2

Publication offers labs consensus recommendations for diagnosing parasitic diseases Opening a channel for salt retention Extreme nausea and vomiting varies among pregnant women from different countries

Chaperone Sampler Kit from BD Biosciences Pharmingen

SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen

Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend

Caveolin Sampler Kit from BD Biosciences Pharmingen

Biology Products:

Chaperone Sampler Kit from BD Biosciences Pharmingen SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend Caveolin Sampler Kit from BD Biosciences Pharmingen

Signatec Unveils PX14400, Its High-Speed PCI-Express Digitizer Capable of Sustained Recordings Over 1.2 GB/s with Xilinx Virtex-5 FPGAs for Embedded Real-Time ...(tribute to a broad selection of industry...)